Skip to main content
Erschienen in: Acta Neuropathologica 1/2003

01.07.2003 | Regular Paper

Lewy body densities in the entorhinal and anterior cingulate cortex predict cognitive deficits in Parkinson's disease

verfasst von: Enikö Kövari, Gabriel Gold, François R. Herrmann, Alessandra Canuto, Patrick R. Hof, Constantin Bouras, Panteleimon Giannakopoulos

Erschienen in: Acta Neuropathologica | Ausgabe 1/2003

Einloggen, um Zugang zu erhalten

Abstract

Previous studies reported an association between cortical Lewy body (LB) formation and dementia in Parkinson's disease (PD). However, it is unclear whether cognitive decline in this disorder is related to specific patterns of LB distribution within the cerebral cortex. Moreover, the prediction of cognitive status based on concomitant assessment of LB and Alzheimer's disease lesions has led to conflicting results. We performed a clinicopathological study in 22 elderly PD patients in whom parkinsonism preceded cognitive decline by at least 3 years. Cognitive status was assessed prospectively using the clinical dementia rating scale (CDR); quantitative assessment of LB, neurofibrillary tangles (NFT), and senile plaques (SP) was performed in Brodmann areas 9, 21, 24, 40 and the entorhinal cortex. Statistical analysis was performed using both correlation coefficients and logistic regression models. There was a highly significant correlation between CDR scores and regional LB scores in the entorhinal cortex and area 24. LB and SP densities in the entorhinal cortex accounted for 36.2% and 19.3% of the variability in CDR scores. LB densities in area 24 could explain 25.2% of this variability. NFT densities did not predict cognitive status. In multivariate models only LB densities in the entorhinal cortex and anterior cingulate cortex were significantly associated with CDR scores. These results imply that an assessment of LB pathology limited to the entorhinal cortex and area 24 may be sufficient to predict cognition in PD. They also suggest that LB formation in limbic areas may be crucial for the development of PD dementia.
Literatur
1.
Zurück zum Zitat Aarsland D, Tandberg E, Larsen JP, Cummings JL (1996) Frequency of dementia in Parkinson disease. Arch Neurol 53:538–542PubMed Aarsland D, Tandberg E, Larsen JP, Cummings JL (1996) Frequency of dementia in Parkinson disease. Arch Neurol 53:538–542PubMed
2.
Zurück zum Zitat Apaydin H, Ahlskog E, Parisi JE, Boeve BF, Dickson DW (2002) Parkinson disease neuropathology. Arch Neurol 59:102–112CrossRefPubMed Apaydin H, Ahlskog E, Parisi JE, Boeve BF, Dickson DW (2002) Parkinson disease neuropathology. Arch Neurol 59:102–112CrossRefPubMed
3.
Zurück zum Zitat Braak H, Braak E (1990) Cognitive impairment in Parkinson's disease: amyloid plaques, neurofibrillary tangles and neuropil threads in the cerebral cortex. J Neural Transm 2:45–47 Braak H, Braak E (1990) Cognitive impairment in Parkinson's disease: amyloid plaques, neurofibrillary tangles and neuropil threads in the cerebral cortex. J Neural Transm 2:45–47
4.
Zurück zum Zitat Braak H, Braak E, Yilmazer D, Vos RA de, Jansen EN, Bohl J (1996) Pattern of brain destruction in Parkinson's disease and Alzheimer's disease. J Neural Transm 103:455–490PubMed Braak H, Braak E, Yilmazer D, Vos RA de, Jansen EN, Bohl J (1996) Pattern of brain destruction in Parkinson's disease and Alzheimer's disease. J Neural Transm 103:455–490PubMed
5.
Zurück zum Zitat Braak H, Del Tredici K, Bohl J, Bratzke H, Braak E (2000) Pathological changes in the parahippocampal region in select non-Alzheimer's dementias. Ann N Y Acad Sci 911:221–239PubMed Braak H, Del Tredici K, Bohl J, Bratzke H, Braak E (2000) Pathological changes in the parahippocampal region in select non-Alzheimer's dementias. Ann N Y Acad Sci 911:221–239PubMed
6.
Zurück zum Zitat Churchyard A, Lees AJ (1997) The relationship between dementia and direct involvement of the hippocampus and amygdala in Parkinson's disease. Neurology 49:1570–1576PubMed Churchyard A, Lees AJ (1997) The relationship between dementia and direct involvement of the hippocampus and amygdala in Parkinson's disease. Neurology 49:1570–1576PubMed
7.
Zurück zum Zitat Delacourte A, Flament S, Dibe EM, Hublau P, Sablonniere B, Hemon B, Sherrer V, Defossez A (1990) Pathological proteins Tau 64 and 69 are specifically expressed in the somatodendritic domain of the degenerating cortical neurons during Alzheimer's disease. Demonstration with a panel of antibodies against Tau proteins. Acta Neuropathol 80:111–117PubMed Delacourte A, Flament S, Dibe EM, Hublau P, Sablonniere B, Hemon B, Sherrer V, Defossez A (1990) Pathological proteins Tau 64 and 69 are specifically expressed in the somatodendritic domain of the degenerating cortical neurons during Alzheimer's disease. Demonstration with a panel of antibodies against Tau proteins. Acta Neuropathol 80:111–117PubMed
8.
Zurück zum Zitat Devinsky O, Morrell MJ, Vogt BA (1995) Contributions of anterior cingulate cortex to behaviour. Brain 118:279–306PubMed Devinsky O, Morrell MJ, Vogt BA (1995) Contributions of anterior cingulate cortex to behaviour. Brain 118:279–306PubMed
9.
Zurück zum Zitat Duyckaerts C, Gaspar P, Costa C, Bonnet A-M, Hauw J-J (1993) Dementia in Parkinson's disease. Morphometric data. Adv Neurol 60:447–455PubMed Duyckaerts C, Gaspar P, Costa C, Bonnet A-M, Hauw J-J (1993) Dementia in Parkinson's disease. Morphometric data. Adv Neurol 60:447–455PubMed
10.
Zurück zum Zitat Hansen LA (1997) The Lewy body variant of Alzheimer disease. J Neural Transm Suppl 51:83–93PubMed Hansen LA (1997) The Lewy body variant of Alzheimer disease. J Neural Transm Suppl 51:83–93PubMed
11.
Zurück zum Zitat Harding AJ, Stimson E, Henderson JM, Halliday GM (2002) Clinical correlates of selective pathology in the amygdala of patients with Parkinson's disease. Brain 125:2431–2445CrossRefPubMed Harding AJ, Stimson E, Henderson JM, Halliday GM (2002) Clinical correlates of selective pathology in the amygdala of patients with Parkinson's disease. Brain 125:2431–2445CrossRefPubMed
12.
Zurück zum Zitat Heyman A, Fillenbaum GG, Gearing M, Mirra SS, Welsh-Bohmer KA, Peterson B, Pieper C (1999) Comparison of Lewy body variant of Alzheimer's disease with pure Alzheimer's disease: Consortium to Establish a Registry for Alzheimer's Disease, Part XIX. Neurology 52:1839–1844PubMed Heyman A, Fillenbaum GG, Gearing M, Mirra SS, Welsh-Bohmer KA, Peterson B, Pieper C (1999) Comparison of Lewy body variant of Alzheimer's disease with pure Alzheimer's disease: Consortium to Establish a Registry for Alzheimer's Disease, Part XIX. Neurology 52:1839–1844PubMed
13.
Zurück zum Zitat Hurtig HI, Trojanowski JQ, Galvin J, Ewbank D, Schmidt ML, Lee VM, Clark CM, Glosser G, Stern MB, Gollomp SM, Arnold SE (2000) Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease. Neurology 54:1916–1921PubMed Hurtig HI, Trojanowski JQ, Galvin J, Ewbank D, Schmidt ML, Lee VM, Clark CM, Glosser G, Stern MB, Gollomp SM, Arnold SE (2000) Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease. Neurology 54:1916–1921PubMed
14.
Zurück zum Zitat Ince P, Irving D, MacArthur F, Perry RH (1991) Quantitative neuropathological study of Alzheimer-type pathology in the hippocampus: comparison of senile dementia of Alzheimer type, senile dementia of Lewy body type, Parkinson's disease and non-demented elderly control patients. J Neurol Sci 106:142–151PubMed Ince P, Irving D, MacArthur F, Perry RH (1991) Quantitative neuropathological study of Alzheimer-type pathology in the hippocampus: comparison of senile dementia of Alzheimer type, senile dementia of Lewy body type, Parkinson's disease and non-demented elderly control patients. J Neurol Sci 106:142–151PubMed
15.
Zurück zum Zitat Ito K, Nagano-Saito A, Kato T, Arahata Y, Nakamura A, Kawasumi Y, Hatano K, Abe Y, Yamada T, Kachi T, Brooks DJ (2002) Striatal and extrastriatal dysfunction in Parkinson's disease with dementia: a 6-[18F]fluoro-l-dopa PET study. Brain 125:1358–1365CrossRefPubMed Ito K, Nagano-Saito A, Kato T, Arahata Y, Nakamura A, Kawasumi Y, Hatano K, Abe Y, Yamada T, Kachi T, Brooks DJ (2002) Striatal and extrastriatal dysfunction in Parkinson's disease with dementia: a 6-[18F]fluoro-l-dopa PET study. Brain 125:1358–1365CrossRefPubMed
16.
Zurück zum Zitat Jendroska K, Lees AJ, Poewe W, Daniel SE (1996) Amyloid β-peptide and the dementia of Parkinson's disease. Mov Disord 11:647–653PubMed Jendroska K, Lees AJ, Poewe W, Daniel SE (1996) Amyloid β-peptide and the dementia of Parkinson's disease. Mov Disord 11:647–653PubMed
17.
Zurück zum Zitat Kim KS, Miller DL, Sapienza VG, Chen CCJ, Vai C, Grundke-Iqbal I, Curry JR, Wisniewski HM (1988) Production and characterization of monoclonal antibodies reactive to synthetic cerebrovascular amyloid peptide. Neurosci Res Commun 2:121–130 Kim KS, Miller DL, Sapienza VG, Chen CCJ, Vai C, Grundke-Iqbal I, Curry JR, Wisniewski HM (1988) Production and characterization of monoclonal antibodies reactive to synthetic cerebrovascular amyloid peptide. Neurosci Res Commun 2:121–130
18.
Zurück zum Zitat Lippa CF, Smith TW, Swearer JM (1994) Alzheimer's disease and Lewy body disease: a comparative clinicopathological study. Ann Neurol 35:81–88PubMed Lippa CF, Smith TW, Swearer JM (1994) Alzheimer's disease and Lewy body disease: a comparative clinicopathological study. Ann Neurol 35:81–88PubMed
19.
Zurück zum Zitat Mahler ME, Cummings JL (1990) Alzheimer disease and the dementia of Parkinson disease: comparative investigations. Alzheimer Dis Assoc Disord 4:133–149PubMed Mahler ME, Cummings JL (1990) Alzheimer disease and the dementia of Parkinson disease: comparative investigations. Alzheimer Dis Assoc Disord 4:133–149PubMed
20.
Zurück zum Zitat Marder K, Tang MX, Cote L, Stern Y, Mayeux R (1995) The frequency and associated risk factors for dementia in patients with Parkinson's disease. Arch Neurol 52:695–701PubMed Marder K, Tang MX, Cote L, Stern Y, Mayeux R (1995) The frequency and associated risk factors for dementia in patients with Parkinson's disease. Arch Neurol 52:695–701PubMed
21.
Zurück zum Zitat Mattila PM, Roytta M, Torikka H, Dickson DW, Rinne JO (1998) Cortical Lewy bodies and Alzheimer-type changes in patients with Parkinson's disease. Acta Neuropathol 95:576–582CrossRefPubMed Mattila PM, Roytta M, Torikka H, Dickson DW, Rinne JO (1998) Cortical Lewy bodies and Alzheimer-type changes in patients with Parkinson's disease. Acta Neuropathol 95:576–582CrossRefPubMed
22.
Zurück zum Zitat Mattila PM, Rinne JO, Helenius H, Dickson DW, Röyttä M (2000) Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease. Acta Neuropathol 100:285–290PubMed Mattila PM, Rinne JO, Helenius H, Dickson DW, Röyttä M (2000) Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease. Acta Neuropathol 100:285–290PubMed
23.
Zurück zum Zitat Mayeux R, Chen J, Mirabello E, Marder K, Bell K, Dooneief G, Cote L, Stern Y (1990) An estimate of the incidence of dementia in idiopathic Parkinson's disease. Neurology 40:1513–1517PubMed Mayeux R, Chen J, Mirabello E, Marder K, Bell K, Dooneief G, Cote L, Stern Y (1990) An estimate of the incidence of dementia in idiopathic Parkinson's disease. Neurology 40:1513–1517PubMed
24.
Zurück zum Zitat Mayeux R, Denaro J, Hemenegildo N, Marder K, Tang MX, Cote LJ, Stern Y (1992) A population-based investigation of Parkinson's disease with and without dementia: relationship to age and gender. Arch Neurol 49:492–497PubMed Mayeux R, Denaro J, Hemenegildo N, Marder K, Tang MX, Cote LJ, Stern Y (1992) A population-based investigation of Parkinson's disease with and without dementia: relationship to age and gender. Arch Neurol 49:492–497PubMed
25.
Zurück zum Zitat McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen EN, Ballard C, Vos RA de, Wilcock GK, Jellinger KA, Perry RH (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47:1113–1124PubMed McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen EN, Ballard C, Vos RA de, Wilcock GK, Jellinger KA, Perry RH (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47:1113–1124PubMed
26.
Zurück zum Zitat McKeith IG, Ballard CG, Perry RH, Ince PG, O'Brien JT, Neill D, Lowery K, Jaros E, Barber R, Thompson P, Swann A, Fairbairn AF, Perry EK (2000) Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies. Neurology 54:1050–1058PubMed McKeith IG, Ballard CG, Perry RH, Ince PG, O'Brien JT, Neill D, Lowery K, Jaros E, Barber R, Thompson P, Swann A, Fairbairn AF, Perry EK (2000) Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies. Neurology 54:1050–1058PubMed
27.
Zurück zum Zitat Morris JC (1993) The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 43:2412–2414 Morris JC (1993) The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 43:2412–2414
28.
Zurück zum Zitat Newell KL, Hyman BT, Growdon JH, Hedley-Whyte ET (1999) Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease. J Neuropathol Exp Neurol 58:1147–1155PubMed Newell KL, Hyman BT, Growdon JH, Hedley-Whyte ET (1999) Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease. J Neuropathol Exp Neurol 58:1147–1155PubMed
29.
Zurück zum Zitat Perl DP, Olanow CW, Calne D (1998) Alzheimer's disease and Parkinson's disease: distinct entities or extremes of a spectrum of neurodegeneration? Ann Neurol 44:S19–S31PubMed Perl DP, Olanow CW, Calne D (1998) Alzheimer's disease and Parkinson's disease: distinct entities or extremes of a spectrum of neurodegeneration? Ann Neurol 44:S19–S31PubMed
30.
Zurück zum Zitat Perry RH, Irving D, Blessed G, Fairbairn A, Perry EK (1990) Senile dementia of Lewy body type. A clinically and neuropathologically distinct type of Lewy body dementia in the elderly. J Neurol Sci 95:119–139PubMed Perry RH, Irving D, Blessed G, Fairbairn A, Perry EK (1990) Senile dementia of Lewy body type. A clinically and neuropathologically distinct type of Lewy body dementia in the elderly. J Neurol Sci 95:119–139PubMed
31.
Zurück zum Zitat Sutcliffe RLG, Prior R, Mawby B, McQuillan WJ (1985) Parkinson's disease in the district of the Northampton Health Authority, United Kingdom: a study of prevalence and disability. Acta Neurol Scand 72:363–379PubMed Sutcliffe RLG, Prior R, Mawby B, McQuillan WJ (1985) Parkinson's disease in the district of the Northampton Health Authority, United Kingdom: a study of prevalence and disability. Acta Neurol Scand 72:363–379PubMed
32.
Zurück zum Zitat Tison F, Dartigues JF, Auriacombe S, Letenneur L, Boller F, Alperovitch A (1995) Dementia in Parkinson's disease: a population-based study in ambulatory and instituionalized individuals. Neurology 45:705–708PubMed Tison F, Dartigues JF, Auriacombe S, Letenneur L, Boller F, Alperovitch A (1995) Dementia in Parkinson's disease: a population-based study in ambulatory and instituionalized individuals. Neurology 45:705–708PubMed
33.
Zurück zum Zitat Tyrrell PJ, Sawle GV, Ibanez V, Bloomfield PM, Leenders KL, Frackowiak RS, Rossor MN (1990) Clinical and positron emission tomographic studies in the "extrapyramidal syndrome" of dementia of the Alzheimer type. Arch Neurol 47:1318–1323PubMed Tyrrell PJ, Sawle GV, Ibanez V, Bloomfield PM, Leenders KL, Frackowiak RS, Rossor MN (1990) Clinical and positron emission tomographic studies in the "extrapyramidal syndrome" of dementia of the Alzheimer type. Arch Neurol 47:1318–1323PubMed
34.
Zurück zum Zitat Vallet PG, Guntern R, Hof PR, Golaz J, Delacourte A, Robakis NK, Bouras C (1992) A comparative study of histological and immunohistochemical methods for neurofibrillary tangles and senile plaques in Alzheimer's disease. Acta Neuropathol 83:170–178PubMed Vallet PG, Guntern R, Hof PR, Golaz J, Delacourte A, Robakis NK, Bouras C (1992) A comparative study of histological and immunohistochemical methods for neurofibrillary tangles and senile plaques in Alzheimer's disease. Acta Neuropathol 83:170–178PubMed
35.
Zurück zum Zitat Vogt BA, Finch DM, Olson CR (1992) Functional heterogeneity in cingulate cortex: the anterior executive and posterior evaluative regions. Cereb Cortex 2:435–443PubMed Vogt BA, Finch DM, Olson CR (1992) Functional heterogeneity in cingulate cortex: the anterior executive and posterior evaluative regions. Cereb Cortex 2:435–443PubMed
36.
Zurück zum Zitat Ward CD, Gibb WR (1990) Research diagnosis criteria for Parkinson's disease. Adv Neurol 53:245–249PubMed Ward CD, Gibb WR (1990) Research diagnosis criteria for Parkinson's disease. Adv Neurol 53:245–249PubMed
Metadaten
Titel
Lewy body densities in the entorhinal and anterior cingulate cortex predict cognitive deficits in Parkinson's disease
verfasst von
Enikö Kövari
Gabriel Gold
François R. Herrmann
Alessandra Canuto
Patrick R. Hof
Constantin Bouras
Panteleimon Giannakopoulos
Publikationsdatum
01.07.2003
Verlag
Springer-Verlag
Erschienen in
Acta Neuropathologica / Ausgabe 1/2003
Print ISSN: 0001-6322
Elektronische ISSN: 1432-0533
DOI
https://doi.org/10.1007/s00401-003-0705-2

Weitere Artikel der Ausgabe 1/2003

Acta Neuropathologica 1/2003 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Demenzkranke durch Antipsychotika vielfach gefährdet

Demenz Nachrichten

Der Einsatz von Antipsychotika gegen psychische und Verhaltenssymptome in Zusammenhang mit Demenzerkrankungen erfordert eine sorgfältige Nutzen-Risiken-Abwägung. Neuen Erkenntnissen zufolge sind auf der Risikoseite weitere schwerwiegende Ereignisse zu berücksichtigen.

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.